Clinical Trial Update: Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure

View source ↗

Summary

A clinical trial is investigating how SGLT2 inhibitors affect erythropoiesis in people with heart failure, with active but not recruiting status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Heart Failure, Anemia | Status: ACTIVE_NOT_RECRUITING